What to watch. Gufic Bio: Patent wins may keep it healthy

Gufic Biosciences has received two patent certificates from the Intellectual Property India. In a post-market-hour disclosure, the company said it has received patents for “a freeze dried pharmaceutical composition and process for preparation thereof” and for “a freeze dried parental composition of Tygecycline and process for preparation thereof”. Shares will react positively to the develoment, as Gufic Bio prepares to apply for patent licence in other countries too.